| Literature DB >> 35653341 |
Sören Frahm, Anisuzzaman Anisuzzaman, Ulrich Fabien Prodjinotho, Nermina Vejzagić, Admar Verschoor, Clarissa Prazeres da Costa.
Abstract
[This corrects the article DOI: 10.1371/journal.pntd.0006590.].Entities:
Year: 2022 PMID: 35653341 PMCID: PMC9162321 DOI: 10.1371/journal.pntd.0010513
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 5Efficient drug screening of advanced larval stages of S. mansoni generated in human serum.
NTS were cultured in HM supplemented with 200 U/ml Penicillin and 200 μg/ml Streptomycin and 20% HSe for 1 week to generate LuS (B, D, F and H) and 6 weeks to obtain LiS (A, C, E, G) schistosomula. (A, B) Praziquantel (PZQ), (C, D) Oxamniquine (OXM), (E, F) Mefloquine (MFQ) and (G, H) Artemether (ART) were dissolved in DMSO and added at indicated concentrations for the entire duration of the experiment. 1% DMSO in culture medium served as control. Viability was scored before treatment (0 h) and 3 hours, 1, 2, 3 and 7 days a.t. Each data point is shown as a mean ± SD of three independent experiments with at least three biological replicates each. ××× p ≤ 0.001, ×× p ≤ 0.01, × p ≤ 0.05 comparing control with 1 μg/ml drug; ┴┴┴ p ≤ 0.001 ┴┴ p ≤ 0.01 ┴ p ≤ 0.05 control with 10 μg/ml drug; ***p ≤ 0.001, **p ≤ 0.01 *p ≤ 0.05 control with 100 μg/ml drug. LuS, lung stage; LiS, liver stage; s.p., score points; a.t., after treatment.